Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)
Italy · Delayed Price · Currency is EUR 1.055
-0.025 (-2.31%)
At close: Oct 16, 2026
BIT:ERFO Revenue
Laboratorio Farmaceutico Erfo had revenue of 5.29M EUR in the half year ending June 30, 2026, with 58.94% growth. This brings the company's revenue in the last twelve months to 10.04M, up 22.19% year-over-year. In the year 2025, Laboratorio Farmaceutico Erfo had annual revenue of 9.96M with 57.11% growth. That makes Laboratorio Farmaceutico Erfo the 36,877th largest company in the world by revenue and 331st in Italy.
Revenue (ttm)
10.04M
Revenue Growth
+22.19%
P/S Ratio
0.92
Revenue / Employee
208.83K
Employees
47
Market Cap
8.98M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.96M | 3.62M | 57.11% |
| Dec 31, 2024 | 6.34M | 919.06K | 16.96% |
| Dec 31, 2023 | 5.42M | 402.40K | 8.02% |
| Dec 31, 2022 | 5.02M | -87.15K | -1.71% |
| Dec 31, 2021 | 5.10M | 904.70K | 21.54% |
| Dec 31, 2020 | 4.20M | -481.17K | -10.28% |
| Dec 31, 2019 | 4.68M | 574.43K | 13.99% |
| Dec 31, 2018 | 4.11M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Davide Campari-Milano | 3.04B |
| B.F. S.p.A. | 2.03B |
| Intercos | 1.03B |
| Italmobiliare | 803.88M |
| Centrale del Latte d'Italia | 335.84M |
| Valsoia | 120.51M |
| Enervit | 103.60M |
| Longino & Cardenal | 34.57M |